Zobrazeno 1 - 10
of 130
pro vyhledávání: '"Chahine, LM"'
Autor:
Simuni, T, Merchant, K, Brumm, MC, Cho, H, Caspell-Garcia, C, Coffey, CS, Chahine, LM, Alcalay, RN, Nudelman, K, Foroud, T, Mollenhauer, B, Siderowf, A, Tanner, C, Iwaki, H, Sherer, T, Marek, K, Seibyl, J, Coffey, C, Tosun-Turgut, D, Shaw, LM, Trojanowski, JQ, Singleton, A, Kieburtz, K, Toga, A, Galasko, D, Poewe, W, Poston, K, Bressman, S, Reimer, A, Arnedo, V, Clark, A, Frasier, M, Kopil, C, Chowdhury, S, Casaceli, C, Dorsey, R, Wilson, R, Mahes, S, Salerno, C, Ahrens, M, Brumm, M, Cho, HR, Fedler, J, LaFontant, D-E, Kurth, R, Crawford, K, Casalin, P, Malferrari, G, Weisz, MG, Orr-Urtreger, A, Trojanowski, J, Shaw, L, Montine, T, Baglieri, C, Christini, A, Russell, D, Dahodwala, N, Giladi, N, Factor, S, Hogarth, P, Standaert, D, Hauser, R, Jankovic, J, Saint-Hilaire, M, Richard, I, Shprecher, D, Fernandez, H, Brockmann, K, Rosenthal, L, Barone, P, Espayc, A, Rowe, D, Marder, K, Santiago, A, Hu, S-C, Isaacson, S, Corvol, J-C, Martinez, JR, Tolosa, E, Tai, Y, Politis, M, Smejdir, D, Rees, L, Williams, K, Kausar, F, Richardson, W, Willeke, D, Peacock, S, Sommerfeld, B, Freed, A, Wakeman, K, Blair, C, Guthrie, S, Harrell, L, Hunter, C, Thomas, C-A, James, R, Zimmerman, G, Brown, V, Mule, J, Hilt, E, Ribb, K, Ainscough, S, Wethington, M, Ranola, M, Santana, HM, Moreno, J, Raymond, D, Speketer, K, Carvajal, L, Carvalo, S, Croitoru, I, Garrido, A, Payne, LM, Viswanth, V, Severt, L, Facheris, M, Soares, H, Mintun, MA, Cedarbaum, J, Taylor, P, Biglan, K, Vandenbroucke, E, Sheikh, ZH, Bingol, B, Fischer, T, Sardi, P, Forrat, R, Reith, A, Egebjerg, J, Hillert, GA, Saba, B, Min, C, Umek, R, Mather, J, De Santi, S, Post, A, Boess, F, Taylor, K, Grachev, I, Avbersek, A, Muglia, P, Tauscher, J
We examined 2-year longitudinal change in clinical features and biomarkers in LRRK2 non-manifesting carriers (NMCs) versus healthy controls (HCs) enrolled in the Parkinson’s Progression Markers Initiative (PPMI). We analyzed 2-year longitudinal dat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::57cb78cbdcff5c5771194646efb11352
http://hdl.handle.net/10044/1/101202
http://hdl.handle.net/10044/1/101202
Autor:
Chahine, LM, Siderowf, A, Barnes, J, Seedorff, N, Caspell-Garcia, C, Simuni, T, Coffey, CS, Galasko, D, Mollenhauer, B, Arnedo, V, Daegele, N, Frasier, M, Tanner, C, Kieburtz, K, Marek, K, Seibyl, J, Coffey, C, Tosun-Turgut, D, Shaw, L, Trojanowski, J, Singleton, A, Toga, A, Chahine, L, Poewe, W, Foroud, T, Poston, K, Sherer, T, Chowdhury, S, Kopil, C, Casaceli, C, Dorsey, R, Wilson, R, Mahes, S, Salerno, C, Crawford, K, Casalin, P, Malferrari, G, Weisz, MG, Orr-Urtreger, A, Montine, T, Russell, D, Dahodwala, N, Giladi, N, Factor, S, Hogarth, P, Standaert, D, Hauser, R, Jankovic, J, Saint-Hilaire, M, Richard, I, Shprecher, D, Fernandez, H, Brockmann, K, Rosenthal, L, Barone, P, Espay, A, Rowe, D, Marder, K, Santiago, A, Bressman, S, Hu, S-C, Isaacson, S, Corvol, J-C, Ruiz Martinez, J, Tolosa, E, Tai, Y, Politis, M, Smejdir, D, Rees, L, Williams, K, Kausar, F, Richardson, W, Willeke, D, Peacock, S, Sommerfeld, B, Freed, A, Wakeman, K, Blair, C, Guthrie, S, Harrell, L, Hunter, C, Thomas, C-A, James, R, Zimmerman, G, Brown, V, Mule, J, Hilt, E, Ribb, K, Ainscough, S, Wethington, M, Ranola, M, Santana, HM, Moreno, J, Raymond, D, Speketer, K, Carvajal, L, Carvalho, S, Croitoru, I, Garrido, A, Payne, LM, Viswanth, V, Severt, L, Facheris, M, Soares, H, Mintun, MA, Cedarbaum, J, Taylor, P, Biglan, K, Vandenbroucke, E, Sheikh, ZH, Bingol, B, Fischer, T, Sardi, P, Forrat, R, Reith, A, Egebjerg, J, Hillert, GA, Saba, B, Min, C, Umek, R, Mather, J, De Santi, S, Post, A, Boess, F, Taylor, K, Grachev, I, Avbersek, A, Muglia, P, Merchant, K, Tauscher, J
Publikováno v:
Journal of Parkinson's Disease
Author(s): Chahine, Lana M; Siderowf, Andrew; Barnes, Janel; Seedorff, Nicholas; Caspell-Garcia, Chelsea; Simuni, Tanya; Coffey, Christopher S; Galasko, Douglas; Mollenhauer, Brit; Arnedo, Vanessa; Daegele, Nichole; Frasier, Mark; Tanner, Caroline; K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f1b94f69531f368cb4c876107d60d08
http://resolver.sub.uni-goettingen.de/purl?gs-1/16631
http://resolver.sub.uni-goettingen.de/purl?gs-1/16631
Autor:
Chahine, LM, Qiang, JK, Ashbridge, E, Minger, J, Yearout, D, Horn, S, Colcher, A, Hurtig, H, Lee, VM, Van Deerlin, VM, Leverenz, JB, Siderowf, A, Trojanowski, JQ, Zabetian, CP, Chen-Plotkin, A
Biochemical abnormalities present in GBA (mut/wt) carriers may offer new pathogenetic insights to and potential therapeutic targets in Parkinson disease (PD).To determine whether patients having PD with vs without GBA mutations differ in clinical phe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1aec9d9dd6e5446ccd39a4d6dfae3ef1
https://europepmc.org/articles/PMC3762458/
https://europepmc.org/articles/PMC3762458/
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Parkinsonism & Related Disorders. Mar2011, Vol. 17 Issue 3, p208-211. 4p.
Autor:
Chahine LM, Chemali Z
Publikováno v:
Eastern Mediterranean Health Journal; nov/dic2009, Vol. 15 Issue 6, p1596-1612, 17p
Publikováno v:
Eastern Mediterranean Health Journal; nov/dic2008, Vol. 14 Issue 6, p1466-1476, 11p
Autor:
Chahine LM, Chemali ZN
Publikováno v:
International Journal of Psychiatry in Medicine; 2006, Vol. 36 Issue 3, p333-338, 6p
Autor:
Chahine LM, Berg MJ
Publikováno v:
Neurology; 9/1/2009, Vol. 73 Issue 9, pe44-9, 1p
Autor:
Dam T; Biogen, Boston, MA, USA., Pagano G; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Brumm MC; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA., Gochanour C; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA., Poston KL; Department of Neurology, Stanford University School of Medicine, Palo Alto, CA, USA., Weintraub D; University of Pennsylvania and the Parkinson's Disease and Mental Illness Research, Education and Clinical Centers (PADRECC and MIRECC), Philadelphia Veterans Affairs Medical Center, Philadelphia, PA, USA., Chahine LM; Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA., Coffey C; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA., Tanner CM; Department of Neurology, Movement Disorders and Neuromodulation Center, Weill Institute for Neuroscience, University of California, San Francisco, CA, USA., Kopil CM; The Michael J. Fox Foundation for Parkinson's Research, New York, NY, USA., Xiao Y; The Michael J. Fox Foundation for Parkinson's Research, New York, NY, USA., Chowdhury S; The Michael J. Fox Foundation for Parkinson's Research, New York, NY, USA., Concha-Marambio L; Amprion Inc., San Diego, CA, USA., DiBiaso P; Patient Council, The Michael J. Fox Foundation for Parkinson's Research, New York, NY, USA.; Clinical Solutions and Strategic Partnerships, WCG Clinical, Princeton, NJ, USA., Foroud T; Department of Medical and Molecular Genetics, Indiana University, Indianapolis, IN, USA., Frasier M; The Michael J. Fox Foundation for Parkinson's Research, New York, NY, USA., Jennings D; Denali Therapeutics Inc., South San Francisco, CA, USA., Kieburtz K; Department of Neurology, University of Rochester Medical Center, Rochester, NY, USA., Merchant K; Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Mollenhauer B; Department of Neurology, University Medical Center Göttingen and Paracelsus-Elena-Klinik, Kassel, Germany., Montine TJ; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA., Nudelman K; Department of Medical and Molecular Genetics, Indiana University, Indianapolis, IN, USA., Seibyl J; Institute for Neurodegenerative Disorders, New Haven, CT, USA., Sherer T; The Michael J. Fox Foundation for Parkinson's Research, New York, NY, USA., Singleton A; National Institute on Aging, National Institutes of Health, Bethesda, MD, USA., Stephenson D; Critical Path for Parkinson's, Critical Path Institute, Tucson, AZ, USA., Stern M; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Soto C; Amprion Inc., San Diego, CA, USA.; Department of Neurology, Mitchell Center for Alzheimer's Disease and Related Brain Disorders, University of Texas McGovern Medical School at Houston, Houston, TX, USA., Tolosa E; Parkinson's Disease and Movement Disorders Unit, Neurology Service, Hospital Clínic de Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain., Siderowf A; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Dunn B; The Michael J. Fox Foundation for Parkinson's Research, New York, NY, USA., Simuni T; Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. tsimuni@nm.org., Marek K; Institute for Neurodegenerative Disorders, New Haven, CT, USA.
Publikováno v:
NPJ Parkinson's disease [NPJ Parkinsons Dis] 2024 Sep 27; Vol. 10 (1), pp. 178. Date of Electronic Publication: 2024 Sep 27.